Strategic Forecast for the Tissue Diagnostic Industry: Market Outlook 2025-2034

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Tissue Diagnostic Market Size Growth Forecast: What to Expect by 2025?
The dimensions of the tissue diagnostic market have expanded swiftly in the past few years. It is projected to advance from $5.77 billion in 2024 to $6.38 billion in 2025, with a compound annual growth rate (CAGR) of 10.5%. The expansion during the prior years can be credited to factors like an aging population, the incidence of cancer, technological progression, elevated consciousness of diseases, and efficiency in pathology workflow.

How Will the Tissue Diagnostic Market Size Evolve and Grow by 2029?
The market size of tissue diagnostics is predicted to experience fast growth in the coming years. It's projected to expand to $10.58 billion in 2029 with a compound annual growth rate (CAGR) of 13.5%. Factors contributing to this growth within the future period includes increased usage of personalized medicine, the emergence of liquid biopsies, the acceptance of AI and machine learning, expansion of telepathology, and less invasive techniques. Primary trends during this forecast period involve digital pathology, artificial intelligence (AI), telepathology services, multiplex staining and imaging, and genomic data integration.

View the full report here:
https://www.thebusinessresearchcompany.com/report/tissue-diagnostic-global-market-report

What Drivers Are Propelling the Growth of Tissue Diagnostic Market Forward?
The escalating occurrences of cancer are forecasted to spur the expansion of the tissue diagnostic market. Cancer is initiated when genetic alterations trigger uncontrolled cell growth that destroys body tissues and forms a mass known as a tumor, which can be either cancerous or benign. Various factors such as genetic mutations, carcinogens, smoking, obesity, radiation, hormones, and more could cause cancer. With the rise in cancer cases, there will be an urgent need for diagnostic procedures like tissue diagnostics to help ascertain the disease's condition. For example, the World Health Organization, a UN agency based in Switzerland, predicted in February 2024 that over 35 million new cancer cases would emerge in 2050, marking a 77% surge from the projected 20 million cases in 2022. Consequently, the growing prevalence of cancer is fueling the expansion of the tissue diagnostic market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6505&type=smp

Which Emerging Trends Are Transforming the Tissue Diagnostic Market in 2025?
The increasing focus on product innovation is a notable trend in the tissue diagnostic market. This includes the advent of novel products and solutions capable of collecting various sample types, simultaneous testing of multiple samples, and automation of laboratory processes, thereby, democratizing access. Major market players are actively pursuing the development and provision of these automated tissue diagnostic tools to enhance their market positioning and revenue generation. For example, in June 2022, Roche, a healthcare firm based in Switzerland, launched the Benchmark ULTRA PLUS system, specifically designed for cancer diagnostics. The BenchMark ULTRA PLUS tissue staining system incorporates a range of innovative features including optimized workflow, testing efficiency, and eco-friendly attributes. These enhancements enable pathologists to deliver high-quality results in a timely manner to both medical professionals and patients. The system comes equipped with innovative additions like intuitive software, remote monitoring capabilities, an integrated touchscreen for improved user experience, and a more environmentally sensitive waste system and product packaging.

What Are the Key Segments in the Tissue Diagnostic Market?
The tissue diagnostic market covered in this report is segmented -

1) By Product: Consumables, Antibodies, Kits, Reagents, Probes, Instruments, Slide Staining System, Scanner, Tissue Processing system
2) By Technology: Immunohistochemistry (IHC), In Situ Hybridization (ISH), Digital Pathology And Workflow Management, Special Staining
3) By Disease: Breast Cancer, Gastric Cancer, Lymphoma, Prostate Cancer, Non-Small Cell Lung Cancer (NSCLC)
4) By End User: Hospitals, Research Laboratories, Pharmaceutical Companies, Contract Research Organizations

Subsegments:
1) By Consumables: Biopsy Needles, Slides And Cover Slips, Tissue Embedding Materials
2) By Antibodies: Primary Antibodies, Secondary Antibodies, Monoclonal Antibodies, Polyclonal Antibodies
3) By Kits: Diagnostic Kits, Assay Kits, Staining Kits
4) By Reagents: Fixatives, Staining Reagents, Antigen Retrieval Solutions
5) By Probes: Fluorescent Probes, Molecular Probes, Hybridization Probes
6) By Instruments: Microscopes, Tissue Microarray Instruments, Laser Capture Microdissection Instruments
7) By Slide Staining System: Automated Stainers, Manual Staining Systems
8) By Scanner: Digital Slide Scanners, Whole Slide Imaging Systems
9) By Tissue Processing System: Tissue Processors, Embedding Centers, Microtomes

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=6505&type=smp

Who Are the Key Players Shaping the Tissue Diagnostic Market's Competitive Landscape?
Major companies operating in the tissue diagnostic market include F. Hoffmann-La Roche Ltd., Danaher Corporation, Thermo Fisher Scientific Inc., Abbott Laboratories, Agilent Technologies Inc., Merck KGaA, BioGenex Laboratories, Sakura Finetek Co. Ltd., Philips Healthcare NV, Bio-Rad Laboratories, Ventana Medical Systems Inc., Hologic Inc., Becton dic*kinson and Company, Sysmex Corporation, Cell Signaling Technology Inc., Enzo Life Sciences Inc., Epitomics Inc., Fluidigm Corporation, GE Healthcare Technologies Inc., Genomic Health Inc., Illumina Inc., Leica Microsystems GmbH, Menarini Diagnostics S.r.l, Myriad Genetics Inc., NanoString Technologies Inc., PerkinElmer Inc., QIAGEN N.V., Siemens Healthineers AG, Zeiss Group AG, CytomX Therapeutics Inc.

What Geographic Markets Are Powering Growth in the Tissue Diagnostic Market?
North America was the largest region in the tissue diagnostic market in 2024. The regions covered in the tissue diagnostic market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6505

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.